Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 323

2.
3.

Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group.

Terrier-Lacombe MJ, Guillou L, Maire G, Terrier P, Vince DR, de Saint Aubain Somerhausen N, Collin F, Pedeutour F, Coindre JM.

Am J Surg Pathol. 2003 Jan;27(1):27-39.

PMID:
12502925
4.
6.

Giant cell fibroblastoma associated with dermatofibrosarcoma protuberans: a case report.

Maeda T, Hirose T, Furuya K, Shirakawa K, Kobayashi K.

Mod Pathol. 1998 May;11(5):491-5. Review.

PMID:
9619604
7.

Dermatofibrosarcoma protuberans recurring as a hybrid dermatofibrosarcoma/giant cell fibroblastoma in an adult: a case report.

Warbrick-Smith J, Hollowood K, Birch J.

J Plast Reconstr Aesthet Surg. 2010 Nov;63(11):e785-7. doi: 10.1016/j.bjps.2010.06.026. Epub 2010 Jul 22.

PMID:
20655288
8.

Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.

Mentzel T, Schärer L, Kazakov DV, Michal M.

Am J Dermatopathol. 2007 Oct;29(5):443-8.

PMID:
17890911
9.
10.

Giant cell fibroblastoma with dermatofibrosarcoma protuberans-like transformation.

Perry DA, Schultz LR, Dehner LP.

J Cutan Pathol. 1993 Oct;20(5):451-4.

PMID:
8300930
11.

Genomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans.

Macarenco RS, Zamolyi R, Franco MF, Nascimento AG, Abott JJ, Wang X, Erickson-Johnson MR, Oliveira AM.

Genes Chromosomes Cancer. 2008 Mar;47(3):260-5.

PMID:
18069662
12.

Fibrosarcomatous dermatofibrosarcoma protuberans with giant rosettes.

Zamecnik M.

Am J Dermatopathol. 2001 Feb;23(1):41-5.

PMID:
11176051
14.

Dermatofibrosarcoma protuberans: a clinicopathological analysis of 10 cases in Asians.

Tan AW, Tan SH.

Australas J Dermatol. 2004 Feb;45(1):29-33.

PMID:
14961905
15.

Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.

Sjöblom T, Shimizu A, O'Brien KP, Pietras K, Dal Cin P, Buchdunger E, Dumanski JP, Ostman A, Heldin CH.

Cancer Res. 2001 Aug 1;61(15):5778-83.

16.

Dermatofibrosarcoma protuberans and giant cell fibroblastoma exhibit CD99 positivity.

Diwan AH, Skelton HG 3rd, Horenstein MG, Kelly DR, Barrett TL, Bussian AH, Sanders DY, Lazar AJ, Prieto VG, Smith KJ.

J Cutan Pathol. 2008 Jul;35(7):647-50. doi: 10.1111/j.1600-0560.2007.00872.x. Epub 2008 Jan 14.

PMID:
18201229
17.
18.

Dermatofibrosarcoma protuberans with areas of giant cell fibroblastoma in the vulva: a case report.

Pascual A, Sánchez-Martínez C, Moreno C, Burdaspal-Moratilla A, López-Rodriguez MJ, Rios L.

Eur J Gynaecol Oncol. 2010;31(6):685-9.

PMID:
21319518
19.

Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases.

Reimann JD, Fletcher CD.

Am J Surg Pathol. 2007 Sep;31(9):1371-7.

PMID:
17721193
20.

Giant cell fibroblastoma. A juvenile form of dermatofibrosarcoma protuberans.

Shmookler BM, Enzinger FM, Weiss SW.

Cancer. 1989 Nov 15;64(10):2154-61.

PMID:
2804904

Supplemental Content

Support Center